Lightbridge Corporation Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders Equity and StockBased Compensation (Details Narrative)

Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)				1 Months Ended			12 Months Ended
	Dec. 15, 2022	Dec. 03, 2021	Nov. 09, 2021	Nov. 18, 2022	Nov. 18, 2021	Oct. 29, 2021	Dec. 31, 2022	Dec. 31, 2021	Oct. 27, 2022	Dec. 15, 2021	Nov. 04, 2021	Mar. 25, 2021	Dec. 31, 2020	Oct. 28, 2020
Increased in common stock shares authorized								188,588	25,000,000
Outstanding restricted stock awards							416,316	188,588
Stock option exercise								30,282
Warrants outstanding, total							45,577	45,577
Stock option exercise net proceeds								$ 300,000
Increased in number of shares issued									1,100,000
Convertible restricted stock								188,588
Common stock, shares, outstanding							11,900,217	9,759,223
Shares of common stock issued							11,900,217	9,759,223
Total common stock and all common stock equivalents							12,426,120	10,532,101
Stock options outstanding							525,903
Common stock, shares authorized							25,000,000	25,000,000
Fair value per share							$ 13.23	$ 12.92					$ 14.51
Preferred Stock, Shares Outstanding							0	0
Non-qualified stock options outstanding period							10 years
Non-qualified stock options outstanding							325,571
November 17 2014 [Member]
Warrants outstanding, total							45,577	45,577
Exercise Price							$ 138.60
Purchase Common Shares								45,577
Available-for-sale Securities [Member]
Agreement to sale of company's securities												$ 75,000,000
Aggregate offering price			$ 20,000,000.0				$ 9,000,000.0
Sold of ATM							190,000	2,000,000.0
Proceeds for sale of ATM							$ 1,100,000.0	$ 1,480,000
Employees, Consultants and Directors [Member] \| Short-Term Non-Qualified Options [Member]
Contractual lives period							contractual lives of 2.27 years to 6.92 years
Directors, Officers and Employees [Member] \| Short-Term Non-Qualified Options [Member] \| Advisory board members[Member]
Contractual lives							10 years
Convertible Series B Preferred Stock [Member]
Common stock equivalents shares							12,426,120
Exchange of Outstanding Series A Convertible Preferred Stock for Common Shares
Stock price pershares						$ 9.57
Accrued dividend						$ 800,000
Conversion of Stock, Shares Converted into common stock						262,910
Additional common stock shares issuable						183,098
Additional paid-in capital a deemed dividend						$ 180,000
Liquidation value of common stock						$ 26,000,000
Measurement Input, Conversion Price [Member]
Conversion price						$ 10
Board of Directors Chairman [Member]
Shares of common stock issued							10,565	10,462
Common shares issuances equity grant value	$ 200,000				$ 210,000
Additional common shares	52,085
Accrued expences	$ 200,000
Common shares equity grant price per shares	$ 3.84
Description of common shares issuances					There were 13,096 common shares issued to four directors that vested immediately upon issuance and the remaining 6,548 shares of common shares were issued to the two remaining directors that vested on January 1, 2022
Consultants [Member]
Exercise Price							$ 3.82	$ 3.82
Stock options issued							58,164
Non-qualified stock options granted period							2 to 10-year
Total fair value of stock options							$ 75,000	$ 150,000
Common stock shares issued							7,382
Exercise price lower range limit							$ 3.98	$ 2.58
Exercise price upper range limit							$ 4.75
Non-qualified stock options granted							200,332
Two Consultants [Member]
Stock options issued							18,852
Six Directors [Member]
Shares of common stock issued					19,644
Common stock, shares issued price per share					$ 10.69
Four Directors [Member]
Shares of common stock issued					13,096
Two Directors [Member]
Shares of common stock issued					6,548
Restricted Stock Units (RSUs) [Member]
Common stock, shares, outstanding							416,316	188,588
Restricted Stock Awards outstanding Vested						78,617				157,233	70,265
Compensation expense							$ 700,000	$ 100,000
Weighted-average period							2 years 5 months 4 days
Fair value per share								$ 9.93			$ 6.74
Common shares vested								35,304			157,233
Compensation expected to be expensed								$ 43,313			$ 50,000
Granted to executive officers								78,617			70,265			243,800
RSUs vested						78,617				157,233
Total unrecognized compensation							$ 2,600,000
Restricted Stock Awards \| Board of Directors Chairman [Member]
Common shares issuances equity grant value	$ 140,000				$ 2,000,000		$ 2,000,000
Additional common shares	290,590				188,588			188,588
Common shares equity grant price per shares	$ 4.71				$ 10.69
RSAs expired							188,588
2020 Equity Incentive Plan [Member]
Shares of common stock issued									650,000
Common stock, shares authorized									13,500,000
Exchange of Outstanding Series B Convertible Preferred Stock for Common Shares
Stock price pershares		$ 7.57
Issued of aggregate shares of common stock		522,244
Conversion price		$ 1.8
Conversion of Stock, Shares Converted into common stock		232,111
Accrued and unpaid dividends per share amount		$ 10.00
Additional paid-in capital a deemed dividend		$ 180,000
Preferred Stock, Shares Outstanding		2,666,667
Non-vested stock options [Member]
Weighted-average period							2 years 21 days
Aggregate intrinsic value							$ 5,000	$ 238,000
Net unrecognized compensation cost							42,000	42,000
Vested Stock Options [Member]
Aggregate intrinsic value							$ 5,000	$ 225,000
Omnibus Incentive Plan [Member]
Weighted average recognition period							4 months 10 days
First Tranche [Member]
Restricted Stock Awards outstanding				62,862
Company withheld common shares				21,794
Stock price pershares				$ 4.80
Payment of withholding taxes				$ 10,000
Shares of common stock issued				41,068
Restricted Stock Awards outstanding Vested				62,862
Maximum [Member]
Exercise Price								$ 75.60
Common stock, shares issued price per share							$ 75.60	28.08
Contractual lives							6 years 11 months 1 day
Term of options							10 years
Maximum [Member] \| Employees, Consultants and Directors [Member] \| Short-Term Non-Qualified Options [Member]
Exercise Price							$ 75.60
Contractual lives							9 years 8 months 1 day
Maximum [Member] \| Consultants [Member] \| Short-Term Non-Qualified Options [Member] \| Advisory board members[Member]
Exercise Price								75.60
Maximum [Member] \| Chief Executive Officer [Member] \| Short-Term Non-Qualified Options [Member] \| Advisory board members[Member]
Contractual lives							6 years 11 months 1 day
Non-qualified stock options outstanding							127,299
Minimum [Member]
Exercise Price								3.82
Common stock, shares issued price per share								$ 2.08
Contractual lives							2 years 3 months 7 days
Term of options							2 years
Minimum [Member] \| Employees, Consultants and Directors [Member] \| Short-Term Non-Qualified Options [Member]
Exercise Price							$ 3.82
Contractual lives							6 years 11 months 1 day
Minimum [Member] \| Chief Executie Officer [Member] \| Short-Term Non-Qualified Options [Member] \| Advisory board members[Member]
Contractual lives							2 years 3 months 7 days
Common Stock
Shares of common stock issued								538,713			86,968
Stock options issued							11,900,217	9,759,223					6,567,110